Boiron SA - Asset Resilience Ratio

Latest as of December 2023: -0.13%

Boiron SA (BOI) has an Asset Resilience Ratio of -0.13% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Boiron SA to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€-747.00K

≈ $-873.32K USD Cash + Short-term Investments

Total Assets

€590.20 Million

≈ $690.01 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2023)

This chart shows how Boiron SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Boiron SA.

Liquid Assets Composition Over Time

This chart breaks down Boiron SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Boiron SA (BOI) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€-747.00K	-0.13%
Total Liquid Assets	€-747.00K	-0.13%

Asset Resilience Insights

Limited Liquidity: Boiron SA maintains only -0.13% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Boiron SA Industry Peers by Asset Resilience Ratio

Compare Boiron SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Piramal Pharma Limited NSE:PPLPHARMA	Drug Manufacturers - Specialty & Generic	0.73%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Boiron SA (2001–2023)

The table below shows the annual Asset Resilience Ratio data for Boiron SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.13%	€-747.00K ≈ $-873.32K	€590.20 Million ≈ $690.01 Million	-0.09pp
2022-12-31	-0.03%	€-260.00K ≈ $-303.97K	€789.49 Million ≈ $923.00 Million	+0.02pp
2021-12-31	-0.05%	€-398.00K ≈ $-465.30K	€770.70 Million ≈ $901.03 Million	0.00pp
2020-12-31	-0.05%	€-397.00K ≈ $-464.13K	€781.82 Million ≈ $914.03 Million	+0.00pp
2019-12-31	-0.05%	€-411.00K ≈ $-480.50K	€764.28 Million ≈ $893.53 Million	-0.06pp
2015-12-31	0.01%	€41.00K ≈ $47.93K	€695.45 Million ≈ $813.05 Million	+0.49pp
2012-12-31	-0.48%	€-2.79 Million ≈ $-3.26 Million	€579.28 Million ≈ $677.24 Million	-0.92pp
2001-12-31	0.44%	€905.00K ≈ $1.06 Million	€205.86 Million ≈ $240.67 Million	--

pp = percentage points

About Boiron SA

PA:BOI France Drug Manufacturers - Specialty & Generic

Market Cap

$428.29 Million

€366.34 Million EUR

Market Cap Rank

#13168 Global

#196 in France

Share Price

€21.10

Change (1 day)

-16.27%

52-Week Range

€21.10 - €31.70

All Time High

€59.48